The pharmaceutical field is seeing a important shift in blood sugar therapy with the emergence of GLP-1 patches. These groundbreaking delivery systems offer a possibly simple choice to injections for individuals living with diabetes mellitus type 2. By bypassing the necessity for frequent pokes,